Veterinary & Animal Health Biologics

Species-tuned microbial biologics. USDA CVB. Real-world performance.

At Mika Biologics, animal health isn’t “human biotech with a different label.” It’s its own world—different anatomy and immunity, barn and hatchery logistics, cost realities measured per head or per flock, and a regulator (USDA APHIS Center for Veterinary Biologics, CVB) with a distinct language and dossier rhythm. That’s exactly where we thrive.

We build engineered probiotics (LBPs), bacterins/VLPs/OMVs, enzymes, and bacteriophages for companion and production species—then package them in formats that actually work: chews, boluses, drenches, water-line powders, sprays, immersion baths, multi-dose vials, and farm-scale packs. Our programmes are written from day one for USDA CVB: Outline of Production, Special Outlines, Master Seed/Cell files, serial consistency, claim-linked potency, and an environmental/biosafety story that lands cleanly in inspection.

Mika Biologics. Microbial systems, audit-ready quality, built for barns, boats, clinics, and hatcheries.

Veterinary & Animal Health Biologics, Mika Biologics

What Veterinary & Animal Health Innovators Value

Species-first design
Dose, route, and presentation tailored to canine, feline, equine, bovine, ovine, caprine, swine, poultry, aquaculture, camelids, cervids, and exotics—validated against how vets and producers actually administer products.

USDA CVB fluency
Control strategies that read as Outline of Production; serial release tests that are simple, repeatable, and claim-linked; dossier supplements that don’t derail timelines.

Microbial-platform depth
LBPs, phage, bacterins, VLPs/OMVs, and enzymes—each with the right upstream, downstream, analytics, and release logic.

Cost and scale discipline
COGS-aware engineering; robust yields without fragile knobs; packaging sized for clinics and farms; logistics that don’t invent a cold chain where none is needed.

Field robustness
Products that survive water quality, feed acids, pelleting heat, daily thermal swings, agitation, and repeated opening—with those realities encoded in stability and IFUs.

Challenge orchestration
CROs that know the species and pathogens; endpoints and statistics aligned to label language; datasets that convert to licensure and renewals.

Current Technical Needs in Veterinary & Animal Health

LBPs (single strains & consortia)
Chassis selection (EcN, Lactobacillus, Bifidobacterium, Bacteroides/Clostridia); auxotrophies/kill-switches; palatable chews for pets; enteric/controlled-release boluses for ruminants; water-line powders for barns; immersion for aquaculture.

Bacterins, VLPs & OMVs
Fermentation-based antigens with clean endotoxin/purity stories; spray and in ovo for poultry; immersion/bath for fish; intranasal and parenteral for pets and equine.

Bacteriophages & phage-derived enzymes
Lytic phage seeds/hosts; TFF + AEX purity; aseptic closed processing (no 0.22 µm); cocktails governed by EOP coverage; water-line, aerosol, bolus, and lyo formats.

Enzymes
Feed digestibility, toxin degradation, otic/topical uses; granulation/coatings that survive pelleting; sachets and pastes for pets; bath stability for aquaculture.

Regulatory packages (USDA CVB)
OOP, Special Outlines, Master Seed/Cell; serial potency constructs; label text aligned to claim evidence; conditional licensure pathways and conversion to full.

Environmental challenge & stability
GLP-appropriate models; freezer↔barn excursions; water chemistry (hardness, chlorination, iron); medicator compatibility; transport shock/vibration; multi-dose puncture realism.

Farm-scale packaging
Pails, bag-in-box, carboys, multi-dose vials, drum concentrates; validated seals, CCI, headspace oxygen budgets, and dispensing ergonomics.

Digital QMS & serial governance
eBatch/LIMS, ALCOA+, DHRs that write themselves; audit trails and serial release tables that inspectors can read in one pass.

Innovation in Veterinary Biologics Today

Smart LBP consortia with non-overlapping nutrient niches and simple interlocks to hold ratios through shipping and storage.

Phage cocktails designed with resistance pressure testing and comparability matrices so composition updates don’t restart CMC from scratch.

OMV/VLP spray & in ovo platforms with droplet spectrum control and embryo safety envelopes baked in.

Enzyme-through-pellet strategies: lipid/polymer coatings, post-pellet liquids, or top-dress sachets chosen by data, not habit.

Microencapsulation & enteric bolusing for ruminant hindgut release; density/geometry for rumen retention when that’s the goal.

Water-line automation with medicator calibration and dilution-over-time recovery—backed by piping mockups and barn trials.

One-Health data tie-ins (optional): isolate libraries and dashboards that inform phage and LBP coverage as farms and clinics evolve.

Microbial-first mastery
E. coli, Pichia, Saccharomyces, Aspergillus/Trichoderma, vesicle producers, engineered anaerobes—each with validated USP/DSP playbooks.

USDA CVB–native dossiers
We write the OOP and Special Outlines in the regulator’s language; seeds/cells files that won’t boomerang; serial potency that maps to the claim.

Formulations that work in the field
Chews that dogs actually eat; boluses that release at the right pH; sprays that cover trays; water-line powders that stay in solution and don’t foul lines.

Challenge orchestration without drama
We define endpoints, randomisation, and power; run GLP-appropriate studies with the right CROs; and fold results straight into label and serial logic.

COGS and supply discipline
Resin/membrane choices for productivity and cleanability; campaign planning around seasonal demand; second-source strategies that survive shortages.

Lifecycle control
Scale-down models that predict; three-batch PPQ that closes cleanly; CPV dashboards that alert early; change control with pre-agreed comparability.

Technical Capabilities That Matter to This Sector

Fermentation
Anaerobic and aerobic bacteria, yeasts, fungi; 1–2,000 L in-house; partner routes higher; ORP/DO control for strict anaerobes; AOX1/GAP strategies for Pichia antigens.

Downstream
Depth filtration, TFF (low shear), AEX/HCIC capture and polish, SEC for particle selectivity; granulation/coating for feed; lyo cycle development with controlled nucleation when useful.

Analytics
CFU with payload activity; PFU with EOP; antigen units with NTA/DLS/EM convergence; enzyme Units in feed/water matrices; endotoxin (LAL/rFC); residuals (HCP, DNA/RNA); sterility/bioburden where route demands.

Regulatory & quality
USDA CVB OOP/Special Outlines, Master Seeds/Cells; conditional licensure packages; labels/IFUs; eBatch/LIMS, ALCOA+, DHRs; APR/PQR exports.

Packaging & logistics
Chews, boluses, drenches, sachets; water-line pouches, carboys, bag-in-box; multi-dose vials; headspace oxygen and MVTR control; shock/vibration and thermal profiles qualified.

Case Examples

Canine LBP chew (enzyme payload)
Palatable beef chew delivering ≥10⁹ CFU and defined Units/chew; moisture and headspace oxygen budgets validated; 24-month ambient label; pantry storage IFU.

Swine phage water-line concentrate
Strictly lytic cocktail; TFF + AEX purity; PFU ≥1×10¹¹/mL; dilution-over-time uniformity through medicators; barn-ambient PFU loss ≤0.2 log at 6 months.

Poultry VLP spray
Spray Dv50 matched to hatchery nozzles; antigen display ELISA; particle size window 90–120 nm; 12-month 2–8 °C with agitation tolerance.

Bovine feed-premix enzyme
Coated granules withstand steam conditioning; post-pellet activity ≥ spec; dust index pass; 6-month ambient shelf-life; no loss with common feed acids.

Aquaculture immersion OMV
Salinity-stable formulation; immersion dose kinetics quantified; particle integrity maintained; stability across 4–18 °C water temperatures.

1) Who regulates veterinary biologics in the US?
USDA APHIS CVB. Dossiers emphasise Outline of Production, Special Outlines, Master Seed/Cell governance, and serial potency/safety tied to label and species.

2) Do you support conditional licensure?
Yes—packages built on a reasonable expectation of efficacy with complete safety/purity/CMC; we then execute the work to convert to full licensure.

3) Which species and routes do you cover?
Companion, equine, bovine, ovine/caprine, swine, poultry (spray, in ovo, water), aquaculture (immersion, feed), camelids, cervids, exotics. Routes include

chew/bolus/paste/drench, water-line, spray, immersion, intranasal, and parenteral.

4) Do you manufacture LBPs and phage as well as vaccines and enzymes?
Yes. LBPs, phage/enzymes, bacterins, VLPs/OMVs, and enzymes—each with species-appropriate formats.

5) How do you make water-line products robust?
We test hardness/chlorination/iron, medicator behaviour, temperature cycles, and plumbing dead-legs; labels encode ppm dosing and flush steps; powders stay soluble and stable.

6) Can you ensure palatability and dose uniformity in chews/pastes?
We run flavour panels, rheology studies, moisture and water activity limits, headspace oxygen budgets, and content-uniformity so each unit delivers label CFU/PFU/antigen.

7) How do you address biosafety for engineered strains?
Kill-switches, auxotrophies, chromosomal integration, AR-gene hygiene, and validated inactivation SOPs; environmental narratives included in dossiers.

8) Do you run challenge studies?
We orchestrate with species-savvy CROs, set endpoints/stats in advance, and pipe data into labels and serial potency logic.

9) Can you supply farm-scale packaging?
Yes—pails, carboys, bag-in-box, multi-dose vials, drum concentrates—with CCI, headspace oxygen control, and transport simulation.

10) Can you support outside the US?
Yes—cross-walks to other regulatory frames while keeping the same evidence spine.

The Future of Veterinary Biologics with Mika

Precision LBP ecosystems that hold ratios across shipping and dosing.
Phage platforms with resistance-aware updating and pre-approved comparability.
Spray/in ovo ecosystems that integrate device telemetry with dose control.
Enzymes by design that survive pelleting and push feed efficiency.
Data-first serials whose potency and stability are predicted, not merely measured.
One-Health bridges where farm surveillance tightens product coverage and value.

Closing Statement

Veterinary biologics earn their keep in barns, on boats, and in clinics—settings where simplicity, reliability, and cost are not negotiable luxuries, but survival requirements. Mika Biologics understands this reality at a cellular and regulatory level. We bring microbial-first mastery, USDA CVB fluency, and field-ready formulation to every program. Whether it’s a live biotherapeutic chew that must hold viability through distribution, a phage cocktail delivered via water lines, a sprayable VLP vaccine for herd protection, or a feed-premix enzyme tuned for gut stability, we don’t just design molecules—we design products that behave in the field and dossiers that pass in Washington.

Our approach sets us apart. We are not a commodity fermentor pushing out bulk broth. We are a true partner that treats manufacturability as a design principle from day one. That means strain evaluation with safety genomics, robust GMP fermentation strategies, stabilization routes tailored to your species and delivery method, and release assays that reflect what matters in real-world deployment. The result: products that farmers, veterinarians, and regulators alike can trust.

By uniting deep technical expertise in microbial expression and formulation with regulatory and clinical awareness, Mika ensures that design, licensure, and supply do not feel like distant hurdles but like natural, inevitable steps on a single continuum. We help you move faster not by cutting corners but by building smarter foundations—platform assays, field-stable formulations, reproducible anaerobic and microaerophilic workflows—that make approvals smoother and scale-ups predictable.

In animal health, success is measured in barns cleared of infection, aquaculture ponds that stay productive, and clinics stocked with safe, affordable biologics. That’s why Mika Biologics is the best Animal Health CDMO: we combine technical rigor with practical wisdom, so your innovation doesn’t just survive a bioreactor run—it thrives in the hands of the people and animals who need it most.